Inhalable Drugs Market Size

  • Report ID: 6562
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Inhalable Drugs Market Size

Inhalable Drugs Market size is estimated at USD 35.8 billion in 2024 and is predicted to reach USD 88.4 billion by the end of 2037, expanding at a CAGR of 7.2% during the forecast period, i.e., 2025-2037. In 2025, the industry size of inhalable drugs is assessed at USD 38.4 billion.

The inhalable medicines are anticipated to exhibit high demand during the forecasted period owing to their ease of use and quick effectiveness. The rising prevalence of chronic respiratory problems such as asthma, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and occupational lung diseases are prime factors fuelling the sales of inhalable drugs.

Research and development focused on the production of advanced medications is set to fuel the sales of modern inhalable drugs in the coming years. For instance, according to the World Health Organization analysis, COPD is the leading cause of death, and around 70% of COPD cases in high-income countries occur due to excessive smoking. Also, asthma is the most common chronic respiratory disease among children. The rising awareness of asthma and treatment is augmenting the demand for inhalers such as bronchodilators and steroids.

Excess intake of psychoactive substances such as alcohol and tobacco coupled with air pollution and chemicals and dust are some of the common factors of chronic respiratory diseases. According to the National Institutes of Health (NIH), alcohol is the major cause of several disorders in underdeveloped and developing countries. For instance, the World Health Organization (WHO) estimates that around 7% of the population across the world above 15 years of age are living with alcohol-related disorders.


Inhalable Drugs Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6562
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global inhalable drugs market will be valued at USD 38.4 billion in 2025.

Expanding at a CAGR of 7.2%, the global market is expected to increase from USD 35.8 billion in 2024 to USD 88.4 billion by 2037.

Some leading companies are AstraZeneca Plc, C.H. Boehringer Sohn AG & Co. KG., Cipla Limited, GlaxoSmithKline Plc, MannKind Corporation, and Merck & Co., Inc.

The dry powder formulation segment is estimated to capture a strong 34.9% of the market share through 2037.

North America is expected to hold 41.4% of the global market share through 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample